Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Aside from the Allelic Burden of JAK2 -V617F, Acquisition of Mutations in Myeloid Gene Panel Is Associated with the Transformation of Myeloproliferative Neoplasm into Secondary AML

Meong Hi Son, MD, Taehyung Kim, MSc, Jae-Sook Ahn, Marc Tyndel, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, MD PhD, Seung-Shin Lee, Seo-Yeon Ahn, Sung-Hoon Jung, Deok-Hwan Yang, MD, Je-Jung Lee, Hee Jeong Park, Seung Hyun Choi, PhD, Zhaolei Zhang, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2016) 128 (22): 4281.

https://doi.org/10.1182/blood.V128.22.4281.4281

Published: 2016

Journal Articles

The Clonal Origins of Leukemic Progression of Myelodysplasia

Taehyung Kim, MSc, Marc Tyndel, Hyeoung Joon Kim, MD, Jae-Sook Ahn, MD PhD, Seung Hyun Choi, PhD, Hee Jeong Park, Yeo-Kyeoung Kim, MD PhD, Deok-Hwan Yang, Je-Jung Lee, Sung-Hoon Jung, Soo Young Kim, Yoo-Hong Min, June-Won Cheong, MD, Sang Kyun Sohn, MD, PhD, Joon Ho Moon, MD, PhD, Murim Choi, Moses Lee, Zhaolei Zhang, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2016) 128 (22): 4307.

https://doi.org/10.1182/blood.V128.22.4307.4307

Published: 2016

Journal Articles

A Novel Micro RNA Signature Identifies a Patient Subset with Poor Prognosis in Core Binding Factor AML

Meong Hi Son, MD, Taehyung Kim, MSc, Marc Tyndel, Mark D. Minden, MD PhD, Zhaolei Zhang, PhD, Leonardo Salmena, PhD

Blood (2016) 128 (22): 1686.

https://doi.org/10.1182/blood.V128.22.1686.1686

Published: 2016

Journal Articles

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

Blood (2016) 128 (22): 52.

https://doi.org/10.1182/blood.V128.22.52.52

Published: 2016

Journal Articles

Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression

Taehyung Simon Kim, PhD, Zhaolei Zhang, PhD, Marc Tyndel, Jae-Sook Ahn, MDPhD, Yeo-Kyeoung Kim, MD, PhD, Seung Hyun Choi, PhD, Hyeoung-Joon Kim, MD PhD, Moses Lee, Murim Choi, Jeffrey H. Lipton, MD PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 2596.

https://doi.org/10.1182/blood.V126.23.2596.2596

Published: 2015

Journal Articles

Whole Exome Sequencing Reveals That DNMT3A and ASXL1 Mutation Are Involved in the Development of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Patients without ABL1 Tyrosine Kinase Domain Mutation

Taehyung Simon Kim, Zhaolei Zhang, PhD, Marc Tyndel, Jae-Sook Ahn, MDPhD, Seunghyun Choi, PhD, Hyeoung Joon Kim, Jeffrey H. Lipton, MD PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 1568.

https://doi.org/10.1182/blood.V126.23.1568.1568

Published: 2015

NARROW

Aside from the Allelic Burden of JAK2 -V617F, Acquisition of Mutations in Myeloid Gene Panel Is Associated with the Transformation of Myeloproliferative Neoplasm into Secondary AML

The Clonal Origins of Leukemic Progression of Myelodysplasia

A Novel Micro RNA Signature Identifies a Patient Subset with Poor Prognosis in Core Binding Factor AML

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression

Whole Exome Sequencing Reveals That DNMT3A and ASXL1 Mutation Are Involved in the Development of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Patients without ABL1 Tyrosine Kinase Domain Mutation

Email alerts

ASH Publications

American Society of Hematology

Aside from the Allelic Burden of JAK2 -V617F, Acquisition of Mutations in Myeloid Gene Panel Is Associated with the Transformation of Myeloproliferative Neoplasm into Secondary AML

The Clonal Origins of Leukemic Progression of Myelodysplasia

A Novel Micro RNA Signature Identifies a Patient Subset with Poor Prognosis in Core Binding Factor AML

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression

Whole Exome Sequencing Reveals That DNMT3A and ASXL1 Mutation Are Involved in the Development of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Patients without ABL1 Tyrosine Kinase Domain Mutation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only